Potential protective bene ts of schisandrin b against severe acute hepatitis in children during the covid-19 pandemic based on a network pharmacology analysis

HIGHLIGHTS

• who: August et al. from the Begum Gulchemonara Trust University, Bangladesh have published the research work: Potential protective bene ts of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis, in the Journal: (JOURNAL) of 11/05/2022
• what: The authors used a series of network pharmacology analyses to understand and characterize pharmacological targets, biological functions, binding capacity, and therapeutic mechanisms of SchB in hepatitis that are related to adenovirus or SARS-CoV-2.
• how: 7 software performed the docking tests between SchB . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.